Biocon Biologics to partner with International Diabetes Federation

Global Head of Market Access & Policy, Biocon Biologics, Alexander Zach, said:"Given our extensive experience in providing affordable insulins globally, we believe we can contribute and support IDF in driving real policy and access actions that will transform lives and diabetes care."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dgClbS
via IFTTT